The added therapeutic efficacy and safety of alefacept in combination with other (systemic) anti‐psoriatics in refractory psoriasis

Abstract

The concomitant use of systemic anti-psoriatic medication in combination with alefacept has a noteworthy impact on efficacy results. No differences in circulating psoriasis-relevant T-cell populations between patients with or without an additional systemic treatment were seen.